{"id":892646,"date":"2025-10-06T09:57:26","date_gmt":"2025-10-06T13:57:26","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/"},"modified":"2025-10-06T09:57:26","modified_gmt":"2025-10-06T13:57:26","slug":"cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/","title":{"rendered":"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET"},"content":{"rendered":"

\nIndividual and institutional investors, advisors, and analysts are invited to attend
\n<\/h2>\n
\n

SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited<\/b> (Nasdaq: CUPR<\/b>) (\u201cCuprina<\/b>\u201d or \u201cthe Company<\/b>\u201d), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company\u2019s management team, including Chief Executive Officer, David Quek, will present at the Skyline Signature Series\u2122 on Wednesday, October 8th<\/sup>, 2025, at 11:00 AM ET.\u00a0 <\/p>\n

This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. All investors must pre-register<\/b>.<\/p>\n\n\n\n\n\n
\n Event:<\/b>\n <\/td>\nSkyline Signature Series\u2122<\/td>\n<\/tr>\n
\n Date:<\/b>\n <\/td>\nWednesday, October 8, 2025<\/td>\n<\/tr>\n
\n Time:<\/b>\n <\/td>\n11:00 AM ET<\/td>\n<\/tr>\n
\n Registration:<\/b>\n <\/td>\n\n https:\/\/us02web.zoom.us\/webinar\/register\/WN_wWWf2nr8QZmKgzx7IaKrXA#\/registration<\/a>
\n \n <\/td>\n<\/tr>\n<\/table>\n

\n ABOUT THE SKYLINE SIGNATURE SERIES\u2122<\/b>
\n
The Skyline Signature Series provides public companies with a convenient and effective forum to communicate their story to a diverse audience of financial professionals through live virtual presentations. Our financial community participants are carefully curated and qualified by Skyline Corporate Communications Group, LLC (SCCG). Each individual must register and be individually vetted by SCCG to attend so that presenters are ensured of a high-quality, informed, and diverse audience of financial professionals.<\/p>\n

SCCG will be compensated by Cuprina Holdings (Cayman) Limited for providing investor relations services relating to the Company\u2019s securities. Please see the 17(b) Disclaimer and Disclosure Statement here: www.skylineccg.com\/disclosures<\/a><\/p>\n

\n About Skyline Corporate Communications Group, LLC
<\/b>Skyline Corporate Communications Group, LLC, with offices in Boston and New York City, is an investor relations and corporate communications firm that provides strategic messaging and investor communications consulting services for public corporations. Skyline delivers strategic assistance for companies in the financial markets and investment community by effectively communicating their corporate message and competitive advantages. Our team has worked with scores of U.S.-listed public companies worldwide across diverse industries and various market caps. We have experience with shareholder activism and crisis communications and also work with late-stage private companies to help prepare them to enter the public marketplace.<\/p>\n

For additional information on Skyline CCG, please visit: www.skylineccg.com<\/a><\/p>\n

\n About Cuprina Holdings (Cayman) Limited
<\/b>We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. For more information, please visit https:\/\/ www.cuprina.com<\/a>.\u00a0 <\/p>\n

\n FORWARD-LOOKING STATEMENTS<\/b>
\n
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute \u201cforward-looking statements\u201d within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words \u201canticipate,\u201d \u201cbelieve,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cshould,\u201d \u201ctarget,\u201d \u201cwill,\u201d \u201cwould\u201d and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the \u201cRisk Factors\u201d section of the preliminary prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Cuprina Holdings (Cayman) Limited specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.<\/p>\n

\n Cuprina Holdings (Cayman) Limited Investor Contact<\/b>
\n
Investor Relations
c\/o Blk 1090 Lower Delta Road #06-08
Singapore 169201
+65 8512 7275
Email: ir@cuprina.com.sg<\/a><\/p>\n

\n Investor Relations Inquiries:<\/b>
\n
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th<\/sup> Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

Individual and institutional investors, advisors, and analysts are invited to attend SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (\u201cCuprina\u201d or \u201cthe Company\u201d), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company\u2019s management team, including Chief Executive Officer, David Quek, will present at the Skyline Signature Series\u2122 on Wednesday, October 8th, 2025, at 11:00 AM ET.\u00a0 This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. All investors must pre-register. Event: Skyline Signature Series\u2122 Date: Wednesday, October 8, 2025 … <\/p>\n

Continue reading “Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-892646","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nCuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Individual and institutional investors, advisors, and analysts are invited to attend SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (\u201cCuprina\u201d or \u201cthe Company\u201d), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company\u2019s management team, including Chief Executive Officer, David Quek, will present at the Skyline Signature Series\u2122 on Wednesday, October 8th, 2025, at 11:00 AM ET.\u00a0 This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. All investors must pre-register. Event: Skyline Signature Series\u2122 Date: Wednesday, October 8, 2025 … Continue reading "Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-06T13:57:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET\",\"datePublished\":\"2025-10-06T13:57:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/\"},\"wordCount\":719,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/\",\"name\":\"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==\",\"datePublished\":\"2025-10-06T13:57:26+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/","og_locale":"en_US","og_type":"article","og_title":"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET - Market Newsdesk","og_description":"Individual and institutional investors, advisors, and analysts are invited to attend SINGAPORE, Oct. 06, 2025 (GLOBE NEWSWIRE) — Cuprina Holdings (Cayman) Limited (Nasdaq: CUPR) (\u201cCuprina\u201d or \u201cthe Company\u201d), a biomedical and biotechnology company dedicated to the development and commercialization of products for the management of chronic wounds and infertility, as well as cosmeceuticals for the health and beauty sector, today announced that the Company\u2019s management team, including Chief Executive Officer, David Quek, will present at the Skyline Signature Series\u2122 on Wednesday, October 8th, 2025, at 11:00 AM ET.\u00a0 This will be a live, interactive online event where investors are invited to ask the Company questions in real-time. All investors must pre-register. Event: Skyline Signature Series\u2122 Date: Wednesday, October 8, 2025 … Continue reading \"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-06T13:57:26+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET","datePublished":"2025-10-06T13:57:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/"},"wordCount":719,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/","name":"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==","datePublished":"2025-10-06T13:57:26+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUzOTg1OSM3MTc4ODkwIzUwMDEyODY3Mg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cuprina-to-present-live-answer-questions-at-skyline-signature-series-on-october-8th-2025-at-1100-am-et\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cuprina to Present Live, Answer Questions, at Skyline Signature Series\u2122 on October 8th, 2025, at 11:00 AM ET"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/892646","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=892646"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/892646\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=892646"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=892646"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=892646"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}